| Class: |
Antiarrhythmic |
| Route: |
IV or IO push only |
Adult Dose: |
Ventricular fibrillation; pulseless ventricular tachycardia
- First Dose - 300 mg - standing order
- Second Dose - 150 mg - standing order
Stable or unstable, sustained ventricular tachycardia with pulse
- 150 mg - over 10 minutes - BIOTEL AUTHORIZATION ONLY
|
| Pediatric Dose: |
Ventricular fibrillation; pulseless ventricular tachycardia; stable, unstable, sustained, or
non-sustained ventricular tachycardia with a pulse
- 5 mg/kg in 100 ml NS slow push over 30 minutes - BIOTEL AUTHORIZATION
ONLY
|
| Drug Action: |
- Alters movement of sodium, potassium and calcium through normal channels thereby
- Increasing the refractory period of all cardiac tissues
- Slowing repolarization
- Decreasing automaticity
- Alpha and beta blocker
|
| Onset: |
Within minutes |
| Duration: |
Variable |
| Indications: |
- Ventricular fibrillation or pulseless ventricular tachycardia that does not respond to initial defibrillation attempts
- Sustained ventricular tachycardia with a pulse
|
| Precautions: |
- Do not shake (prevents foaming); draw-up with large gauge needle
- Protect from light
- Avoid contact with plastic; administer at closest IV port
- Use with caution in renal failure patients
|
| Side Effects: |
|
| Contraindications: |
Trauma patients |